Predictors of treatment interruption among patients on antiretroviral therapy in Akwa Ibom, Nigeria: outcomes after 12 months

被引:2
|
作者
Akpan, Uduak [2 ]
Kakanfo, Kunle [1 ]
Ekele, Oche D. [2 ]
Ukpong, Kufre [2 ]
Toyo, Otoyo [2 ]
Nwaokoro, Pius [1 ]
James, Ezekiel [3 ]
Pandey, Satish [1 ]
Olatubosun, Kolawole [1 ]
Bateganya, Moses [4 ]
机构
[1] FHI 360, Akwa Ibom, Nigeria
[2] Achieving Hlth Nigeria Initiat, Akwa Ibom, Nigeria
[3] US Agcy Int Dev, Abuja, Nigeria
[4] FHI 360, 359 Blackwell St 200, Durham, NC 27701 USA
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2023年 / 35卷 / 01期
关键词
HIV; AIDS; predictors; lost to follow-up; antiretroviral therapy; adults; FOLLOW-UP; RETENTION; INITIATION; PROGRAMS; HIV;
D O I
10.1080/09540121.2022.2093826
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Understanding the characteristics of people living with HIV who interrupt antiretroviral therapy (ART) is critical for designing client-centered services to ensure optimal outcomes. We assessed predictors of treatment interruption in 22 HIV clinics in Nigeria. We reviewed records of HIV-positive patients aged >= 15 years who started ART 1 January and 31 March 2019. We determined treatment status over 12 months as either active, or interrupted treatment (defined as interruption in treatment up to 28 days or longer). Potential predictors were assessed using Cox hazard regression models. Overall, 1185 patients were enrolled on ART, 829 (70%) were female, and median age was 32 years. Retention at 1, 3, 6, 9, and 12 months was 85%, 80%, 76%, 72%, and 68%, respectively. Predictors of treatment interruption were post-secondary education (p = 0.04), diagnosis through voluntary counseling and testing (p < 0.001), receiving care at low-volume facilities (p < 0.001), lack of access to a peer counselor (p < 0.001), and residing outside the clinic catchment area (p = 0.03). Treatment interruption was common but can be improved by focusing on lower volume health facilities, providing peer support especially to those with higher education, and client-centered HIV services for those who live further from clinics..
引用
收藏
页码:114 / 122
页数:9
相关论文
共 50 条
  • [31] CLINICAL OUTCOMES OF CRYPTOCOCCAL MENINGITIS AMONG HIV-INFECTED PATIENTS IN THE ERA OF ANTIRETROVIRAL THERAPY
    Kobayashi, Taiichiro
    Pitisuttithum, Punnee
    Kaewkungwal, Jaranit
    Phuphuakrat, Angsana
    Sungkanuparph, Somnuek
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2017, 48 (01) : 56 - 64
  • [32] Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia
    Teklu, Alula M.
    Yirdaw, Kesetebirhan D.
    BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [33] Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011-2012
    Wang, Jing
    He, Cui
    Hsi, Jenny H.
    Xu, Xiaoqin
    Liu, Yong
    He, Jianmei
    Ling, Hua
    Ding, Ping
    Tong, Yi
    Zou, Xiaobai
    Zhou, Quanhua
    Liao, Lingjie
    Wang, Xia
    Ruan, Yuhua
    Shao, Yiming
    Xing, Hui
    PLOS ONE, 2014, 9 (02):
  • [34] Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda
    Ndahimana, Jean d'Amour
    Riedel, David J.
    Mwumvaneza, Mutagoma
    Sebuhoro, Dieudone
    Uwimbabazi, Jean Claude
    Kubwimana, Marthe
    Mugabo, Jules
    Mulindabigwi, Augustin
    Kirk, Catherine
    Kanters, Steve
    Forrest, Jamie I.
    Jagodzinski, Linda L.
    Peel, Sheila A.
    Ribakare, Muhayimpundu
    Redfield, Robert R.
    Nsanzimana, Sabin
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (07) : 928 - 935
  • [35] HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa
    Hirasen, Kamban
    Fox, Matthew P.
    Hendrickson, Cheryl J.
    Sineke, Tembeka
    Onoya, Dorina
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 : 169 - 180
  • [36] Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria
    Ernest Ekong
    Nicaise Ndembi
    Prosper Okonkwo
    Patrick Dakum
    John Idoko
    Bolanle Banigbe
    James Okuma
    Patricia Agaba
    William Blattner
    Clement Adebamowo
    Manhattan Charurat
    AIDS Research and Therapy, 17
  • [37] Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria
    Ekong, Ernest
    Ndembi, Nicaise
    Okonkwo, Prosper
    Dakum, Patrick
    Idoko, John
    Banigbe, Bolanle
    Okuma, James
    Agaba, Patricia
    Blattner, William
    Adebamowo, Clement
    Charurat, Manhattan
    AIDS RESEARCH AND THERAPY, 2020, 17 (01)
  • [38] Drug therapy problems identified among patients receiving antiretroviral treatment in a HIV clinic: a prospective study in North Central, Nigeria
    Aderemi-Williams, Roseline Iberi
    Nduaguba, Sabina Onyinye
    Akoji, Eric Monday
    Ogbo, Patricia Uche
    Abah, Isaac Okoh
    PAN AFRICAN MEDICAL JOURNAL, 2021, 40
  • [39] Treatment outcomes after early initiation of antiretroviral therapy for human immunodeficiency virus-associated tuberculosis
    Chan, C. K.
    Wong, K. H.
    Leung, C. C.
    Tam, C. M.
    Chan, Kenny C. W.
    Pang, K. W.
    Chan, W. K.
    Mak, Ida K. Y.
    HONG KONG MEDICAL JOURNAL, 2013, 19 (06) : 474 - 483
  • [40] Prevalence and predictors of erectile dysfunctions among men on antiretroviral therapy in South-Western Nigeria
    Adebimpe, W. O.
    Omobuwa, O.
    Adeoye, O. A.
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2015, 5 (04) : 279 - 283